Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiopulmonary Resuscitation | 48 | 2023 | 980 | 6.820 |
Why?
|
Progeria | 22 | 2024 | 185 | 4.520 |
Why?
|
Heart Arrest | 39 | 2022 | 1470 | 4.430 |
Why?
|
Emergency Medical Services | 28 | 2023 | 1917 | 2.260 |
Why?
|
Out-of-Hospital Cardiac Arrest | 12 | 2023 | 339 | 1.840 |
Why?
|
Advanced Cardiac Life Support | 8 | 2022 | 70 | 1.700 |
Why?
|
Hospital Rapid Response Team | 3 | 2022 | 57 | 1.350 |
Why?
|
American Heart Association | 10 | 2022 | 1056 | 1.310 |
Why?
|
Epinephrine | 4 | 2021 | 792 | 0.810 |
Why?
|
Vasoconstrictor Agents | 5 | 2019 | 642 | 0.810 |
Why?
|
Consensus | 11 | 2023 | 2959 | 0.790 |
Why?
|
Heart Massage | 2 | 2017 | 30 | 0.760 |
Why?
|
Piperidines | 7 | 2023 | 1602 | 0.760 |
Why?
|
Intensive Care Units, Pediatric | 11 | 2023 | 981 | 0.730 |
Why?
|
Defibrillators | 1 | 2018 | 37 | 0.630 |
Why?
|
Patient Transfer | 3 | 2016 | 761 | 0.630 |
Why?
|
Child | 68 | 2023 | 77709 | 0.600 |
Why?
|
Dexmedetomidine | 1 | 2022 | 315 | 0.590 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2022 | 632 | 0.580 |
Why?
|
Hospitals, Pediatric | 8 | 2022 | 1775 | 0.500 |
Why?
|
Respiration, Artificial | 10 | 2021 | 2569 | 0.500 |
Why?
|
Pyridines | 6 | 2018 | 2825 | 0.490 |
Why?
|
Emergencies | 3 | 2015 | 1170 | 0.490 |
Why?
|
Lamin Type A | 7 | 2023 | 190 | 0.460 |
Why?
|
Transportation of Patients | 2 | 2015 | 185 | 0.460 |
Why?
|
Quality Indicators, Health Care | 3 | 2017 | 1831 | 0.430 |
Why?
|
Pravastatin | 3 | 2023 | 395 | 0.420 |
Why?
|
Respiratory Insufficiency | 2 | 2010 | 1199 | 0.410 |
Why?
|
Inservice Training | 1 | 2014 | 392 | 0.410 |
Why?
|
Hypotension | 1 | 2018 | 884 | 0.400 |
Why?
|
Child, Preschool | 33 | 2023 | 41006 | 0.390 |
Why?
|
First Aid | 5 | 2023 | 65 | 0.360 |
Why?
|
Pulmonary Surfactants | 1 | 2010 | 162 | 0.350 |
Why?
|
Cardiology | 4 | 2016 | 1668 | 0.340 |
Why?
|
Infant, Newborn | 23 | 2023 | 25625 | 0.340 |
Why?
|
Regional Medical Programs | 1 | 2009 | 71 | 0.340 |
Why?
|
Adolescent | 32 | 2023 | 85781 | 0.330 |
Why?
|
Infant | 26 | 2023 | 35136 | 0.320 |
Why?
|
Pediatrics | 7 | 2022 | 3475 | 0.310 |
Why?
|
Practice Guidelines as Topic | 10 | 2019 | 7279 | 0.290 |
Why?
|
Respiratory Tract Diseases | 2 | 2013 | 722 | 0.290 |
Why?
|
Emergency Treatment | 3 | 2023 | 517 | 0.290 |
Why?
|
Catheterization, Peripheral | 1 | 2010 | 345 | 0.290 |
Why?
|
Humans | 104 | 2024 | 744343 | 0.290 |
Why?
|
Critical Care | 6 | 2022 | 2647 | 0.280 |
Why?
|
Electric Countershock | 4 | 2019 | 534 | 0.280 |
Why?
|
Decision Support Techniques | 1 | 2016 | 1956 | 0.270 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2008 | 476 | 0.250 |
Why?
|
Infant, Premature, Diseases | 1 | 2010 | 706 | 0.240 |
Why?
|
Cardiovascular Agents | 1 | 2010 | 850 | 0.230 |
Why?
|
Critical Illness | 2 | 2022 | 2670 | 0.230 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2014 | 1354 | 0.230 |
Why?
|
Blood Pressure | 3 | 2018 | 8554 | 0.230 |
Why?
|
Retrospective Studies | 21 | 2023 | 77449 | 0.230 |
Why?
|
Resuscitation | 4 | 2022 | 658 | 0.220 |
Why?
|
Nervous System Diseases | 1 | 2013 | 1622 | 0.220 |
Why?
|
Child, Hospitalized | 1 | 2023 | 174 | 0.210 |
Why?
|
Pharmaceutical Preparations | 2 | 2020 | 1071 | 0.200 |
Why?
|
Weaning | 1 | 2022 | 105 | 0.200 |
Why?
|
Premature Birth | 2 | 2023 | 1721 | 0.200 |
Why?
|
Age Determination by Skeleton | 2 | 2020 | 129 | 0.200 |
Why?
|
Cerebral Revascularization | 1 | 2023 | 238 | 0.190 |
Why?
|
Health Resources | 2 | 2017 | 911 | 0.190 |
Why?
|
Moyamoya Disease | 1 | 2023 | 238 | 0.190 |
Why?
|
Diphosphonates | 2 | 2016 | 623 | 0.180 |
Why?
|
Lung Diseases | 2 | 2010 | 1886 | 0.180 |
Why?
|
Midazolam | 1 | 2021 | 270 | 0.180 |
Why?
|
Enzyme Inhibitors | 4 | 2018 | 3798 | 0.180 |
Why?
|
Dystonia | 1 | 2023 | 363 | 0.170 |
Why?
|
Shock, Septic | 3 | 2017 | 775 | 0.170 |
Why?
|
Imidazoles | 2 | 2016 | 1206 | 0.170 |
Why?
|
Dystonic Disorders | 1 | 2023 | 329 | 0.170 |
Why?
|
Laryngoscopes | 1 | 2020 | 148 | 0.160 |
Why?
|
Death, Sudden, Cardiac | 2 | 2016 | 1541 | 0.160 |
Why?
|
Phosphotransferases (Phosphate Group Acceptor) | 1 | 2018 | 18 | 0.160 |
Why?
|
Protein Prenylation | 2 | 2016 | 73 | 0.160 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2016 | 5442 | 0.160 |
Why?
|
Pulmonary Embolism | 2 | 2021 | 2376 | 0.150 |
Why?
|
Teaching Rounds | 1 | 2021 | 253 | 0.150 |
Why?
|
Canada | 1 | 2023 | 2065 | 0.150 |
Why?
|
Heart Diseases | 2 | 2022 | 2788 | 0.150 |
Why?
|
Shock | 1 | 2019 | 318 | 0.150 |
Why?
|
Nursing Assessment | 1 | 2017 | 107 | 0.150 |
Why?
|
Informed Consent | 1 | 2023 | 995 | 0.140 |
Why?
|
Analgesia | 1 | 2021 | 461 | 0.140 |
Why?
|
Hypnotics and Sedatives | 2 | 2022 | 1162 | 0.140 |
Why?
|
Cardiovascular Diseases | 5 | 2022 | 15165 | 0.140 |
Why?
|
Bone Development | 1 | 2020 | 483 | 0.140 |
Why?
|
Young Adult | 11 | 2023 | 56430 | 0.140 |
Why?
|
Hospital Mortality | 3 | 2019 | 5317 | 0.140 |
Why?
|
Near Drowning | 1 | 2015 | 12 | 0.140 |
Why?
|
Adult | 18 | 2023 | 214055 | 0.140 |
Why?
|
Emergency Medical Service Communication Systems | 1 | 2015 | 21 | 0.140 |
Why?
|
Range of Motion, Articular | 1 | 2023 | 1578 | 0.140 |
Why?
|
Sexual Maturation | 1 | 2017 | 265 | 0.140 |
Why?
|
Gingival Recession | 1 | 2018 | 189 | 0.130 |
Why?
|
Walking | 1 | 2023 | 1180 | 0.130 |
Why?
|
Attitude of Health Personnel | 1 | 2009 | 3843 | 0.130 |
Why?
|
Tracheotomy | 1 | 2016 | 166 | 0.130 |
Why?
|
Deep Brain Stimulation | 1 | 2023 | 748 | 0.130 |
Why?
|
Female | 32 | 2023 | 380194 | 0.130 |
Why?
|
Male | 29 | 2023 | 350118 | 0.120 |
Why?
|
Guidelines as Topic | 2 | 2018 | 1405 | 0.120 |
Why?
|
Puberty | 1 | 2017 | 490 | 0.120 |
Why?
|
Hypothermia, Induced | 1 | 2019 | 752 | 0.120 |
Why?
|
Cancer Care Facilities | 1 | 2017 | 402 | 0.120 |
Why?
|
Computer Simulation | 1 | 2008 | 6196 | 0.120 |
Why?
|
Clinical Competence | 3 | 2013 | 4687 | 0.120 |
Why?
|
Perioperative Care | 2 | 2023 | 1002 | 0.110 |
Why?
|
Activities of Daily Living | 1 | 2023 | 2418 | 0.110 |
Why?
|
Neoplasms | 3 | 2017 | 21683 | 0.110 |
Why?
|
Bone and Bones | 3 | 2016 | 2575 | 0.110 |
Why?
|
Stroke | 3 | 2023 | 9981 | 0.110 |
Why?
|
Age Factors | 3 | 2018 | 18370 | 0.110 |
Why?
|
Blood Proteins | 1 | 2018 | 1124 | 0.110 |
Why?
|
Farnesyltranstransferase | 1 | 2012 | 76 | 0.110 |
Why?
|
Arrhythmias, Cardiac | 4 | 2018 | 2268 | 0.110 |
Why?
|
Advisory Committees | 1 | 2016 | 775 | 0.110 |
Why?
|
Alkyl and Aryl Transferases | 2 | 2014 | 89 | 0.100 |
Why?
|
Decision Support Systems, Clinical | 1 | 2021 | 1164 | 0.100 |
Why?
|
Thrombolytic Therapy | 1 | 2021 | 2161 | 0.100 |
Why?
|
Teaching | 2 | 2013 | 1174 | 0.100 |
Why?
|
Airway Management | 1 | 2015 | 329 | 0.100 |
Why?
|
ROC Curve | 2 | 2017 | 3527 | 0.100 |
Why?
|
Eye Diseases | 1 | 2017 | 669 | 0.100 |
Why?
|
Manikins | 1 | 2013 | 238 | 0.100 |
Why?
|
Hospitals | 2 | 2022 | 3952 | 0.100 |
Why?
|
United States | 12 | 2022 | 69872 | 0.100 |
Why?
|
Health Personnel | 3 | 2021 | 3218 | 0.100 |
Why?
|
Clinical Trials as Topic | 4 | 2020 | 7913 | 0.100 |
Why?
|
Health Education | 1 | 2017 | 1056 | 0.090 |
Why?
|
Hyperventilation | 1 | 2010 | 81 | 0.090 |
Why?
|
Decision Making | 2 | 2015 | 3887 | 0.090 |
Why?
|
Protein Precursors | 1 | 2014 | 1154 | 0.090 |
Why?
|
Premedication | 1 | 2010 | 258 | 0.090 |
Why?
|
Erythrocyte Transfusion | 1 | 2014 | 565 | 0.080 |
Why?
|
Case-Control Studies | 5 | 2020 | 21746 | 0.080 |
Why?
|
Cohort Studies | 6 | 2022 | 40561 | 0.080 |
Why?
|
Drug Discovery | 1 | 2016 | 1058 | 0.080 |
Why?
|
Algorithms | 5 | 2020 | 13881 | 0.080 |
Why?
|
Hemoglobins | 1 | 2014 | 1534 | 0.080 |
Why?
|
Heart | 2 | 2018 | 4467 | 0.080 |
Why?
|
Biomedical Research | 1 | 2023 | 3309 | 0.080 |
Why?
|
Recovery of Function | 1 | 2018 | 2925 | 0.080 |
Why?
|
Internship and Residency | 1 | 2008 | 5788 | 0.080 |
Why?
|
Catheter-Related Infections | 1 | 2010 | 252 | 0.080 |
Why?
|
Intubation, Intratracheal | 3 | 2020 | 1364 | 0.070 |
Why?
|
Treatment Outcome | 7 | 2023 | 63114 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14722 | 0.070 |
Why?
|
Guatemala | 2 | 2017 | 142 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2013 | 950 | 0.070 |
Why?
|
Pneumothorax | 1 | 2010 | 379 | 0.070 |
Why?
|
Heart Defects, Congenital | 1 | 2023 | 4584 | 0.070 |
Why?
|
Acute Coronary Syndrome | 3 | 2015 | 2337 | 0.070 |
Why?
|
Risk Factors | 6 | 2021 | 72290 | 0.070 |
Why?
|
Vomiting | 2 | 2023 | 636 | 0.070 |
Why?
|
Parents | 2 | 2021 | 3407 | 0.070 |
Why?
|
Catheterization, Central Venous | 1 | 2010 | 514 | 0.070 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2274 | 0.070 |
Why?
|
Registries | 4 | 2022 | 8089 | 0.070 |
Why?
|
Arsenic Poisoning | 1 | 2005 | 55 | 0.060 |
Why?
|
Patient Admission | 1 | 2013 | 1380 | 0.060 |
Why?
|
Echocardiography | 3 | 2018 | 5102 | 0.060 |
Why?
|
Pneumonia | 1 | 2017 | 2133 | 0.060 |
Why?
|
Carotid Artery Diseases | 1 | 2011 | 882 | 0.060 |
Why?
|
Education, Continuing | 1 | 2005 | 112 | 0.060 |
Why?
|
Carotid Arteries | 3 | 2016 | 952 | 0.060 |
Why?
|
Myocardium | 1 | 2018 | 4776 | 0.060 |
Why?
|
Herbicides | 1 | 2005 | 100 | 0.060 |
Why?
|
Aged | 5 | 2023 | 163280 | 0.060 |
Why?
|
Safety Management | 1 | 2010 | 783 | 0.060 |
Why?
|
Evidence-Based Medicine | 3 | 2010 | 3610 | 0.060 |
Why?
|
Bacteremia | 1 | 2010 | 962 | 0.060 |
Why?
|
Personnel, Hospital | 1 | 2005 | 283 | 0.060 |
Why?
|
Early Diagnosis | 2 | 2019 | 1184 | 0.060 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2023 | 83 | 0.060 |
Why?
|
Sepsis | 1 | 2017 | 2593 | 0.050 |
Why?
|
Delivery of Health Care | 2 | 2018 | 5319 | 0.050 |
Why?
|
Acute Disease | 3 | 2021 | 7149 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15540 | 0.050 |
Why?
|
Emergency Service, Hospital | 3 | 2019 | 7659 | 0.050 |
Why?
|
Video Recording | 2 | 2020 | 949 | 0.050 |
Why?
|
Observer Variation | 1 | 2008 | 2593 | 0.050 |
Why?
|
Capnography | 1 | 2002 | 89 | 0.050 |
Why?
|
Cross Infection | 1 | 2010 | 1416 | 0.050 |
Why?
|
Boston | 4 | 2017 | 9313 | 0.050 |
Why?
|
Chronic Disease | 1 | 2016 | 9146 | 0.050 |
Why?
|
Embolectomy | 1 | 2021 | 120 | 0.050 |
Why?
|
Survival Rate | 1 | 2015 | 12788 | 0.050 |
Why?
|
Infant, Premature | 1 | 2010 | 2044 | 0.050 |
Why?
|
Nausea | 1 | 2023 | 673 | 0.050 |
Why?
|
Infusions, Intraosseous | 1 | 2020 | 9 | 0.050 |
Why?
|
Atropine | 1 | 2020 | 244 | 0.050 |
Why?
|
Skin | 1 | 2014 | 4364 | 0.050 |
Why?
|
Anthropometry | 2 | 2017 | 1350 | 0.040 |
Why?
|
Referral and Consultation | 1 | 2013 | 3528 | 0.040 |
Why?
|
Palliative Care | 1 | 2015 | 3493 | 0.040 |
Why?
|
Prospective Studies | 7 | 2023 | 53288 | 0.040 |
Why?
|
Extracorporeal Circulation | 1 | 2019 | 182 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5853 | 0.040 |
Why?
|
Bone Diseases, Developmental | 1 | 2020 | 130 | 0.040 |
Why?
|
Electronics | 1 | 2020 | 322 | 0.040 |
Why?
|
Absorptiometry, Photon | 2 | 2017 | 1725 | 0.040 |
Why?
|
Aging | 2 | 2022 | 8664 | 0.040 |
Why?
|
Heart Murmurs | 1 | 2018 | 94 | 0.040 |
Why?
|
Myoglobin | 1 | 2018 | 160 | 0.040 |
Why?
|
Interleukin-1alpha | 1 | 2018 | 84 | 0.040 |
Why?
|
Decision Trees | 1 | 2019 | 506 | 0.040 |
Why?
|
Delphi Technique | 1 | 2020 | 778 | 0.040 |
Why?
|
Interleukin-7 | 1 | 2018 | 142 | 0.040 |
Why?
|
Lidocaine | 1 | 2020 | 544 | 0.040 |
Why?
|
Eyebrows | 1 | 2017 | 28 | 0.040 |
Why?
|
Patient Discharge | 2 | 2021 | 3313 | 0.040 |
Why?
|
Injections, Intravenous | 1 | 1999 | 1420 | 0.040 |
Why?
|
beta 2-Microglobulin | 1 | 2018 | 315 | 0.040 |
Why?
|
Pilot Projects | 2 | 2008 | 8324 | 0.040 |
Why?
|
Electric Impedance | 2 | 2010 | 729 | 0.040 |
Why?
|
Refraction, Ocular | 1 | 2017 | 182 | 0.030 |
Why?
|
Hyperthermia, Induced | 1 | 2019 | 403 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2007 | 4803 | 0.030 |
Why?
|
Vital Signs | 1 | 2017 | 142 | 0.030 |
Why?
|
Eyeglasses | 1 | 2017 | 145 | 0.030 |
Why?
|
Interleukin-13 | 1 | 2018 | 389 | 0.030 |
Why?
|
Cause of Death | 2 | 2018 | 3584 | 0.030 |
Why?
|
Conflict of Interest | 2 | 2010 | 544 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 2008 | 2291 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 25043 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6538 | 0.030 |
Why?
|
Radiography | 2 | 2020 | 7023 | 0.030 |
Why?
|
Eyelid Diseases | 1 | 2017 | 155 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2016 | 6489 | 0.030 |
Why?
|
Dimethylallyltranstransferase | 1 | 2014 | 8 | 0.030 |
Why?
|
Systems Analysis | 1 | 2015 | 172 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2023 | 13989 | 0.030 |
Why?
|
Laryngoscopy | 1 | 2020 | 711 | 0.030 |
Why?
|
Checklist | 1 | 2021 | 833 | 0.030 |
Why?
|
Middle Aged | 3 | 2023 | 213383 | 0.030 |
Why?
|
Animals, Newborn | 1 | 1999 | 2726 | 0.030 |
Why?
|
Standard of Care | 1 | 2018 | 564 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2018 | 977 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2019 | 1462 | 0.030 |
Why?
|
Hospitalization | 3 | 2020 | 10262 | 0.030 |
Why?
|
Adenosine | 1 | 2018 | 825 | 0.030 |
Why?
|
Hospital Departments | 1 | 2013 | 137 | 0.030 |
Why?
|
Risk Assessment | 1 | 2013 | 23338 | 0.020 |
Why?
|
Fluid Therapy | 1 | 2015 | 593 | 0.020 |
Why?
|
Rare Diseases | 1 | 2016 | 553 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2014 | 880 | 0.020 |
Why?
|
Ankle Brachial Index | 1 | 2011 | 154 | 0.020 |
Why?
|
Quality Improvement | 2 | 2017 | 3749 | 0.020 |
Why?
|
Stroke Volume | 1 | 2024 | 5007 | 0.020 |
Why?
|
Pulsatile Flow | 1 | 2011 | 332 | 0.020 |
Why?
|
Corneal Diseases | 1 | 2017 | 636 | 0.020 |
Why?
|
Death | 1 | 2015 | 678 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2018 | 1990 | 0.020 |
Why?
|
Family | 1 | 2021 | 3147 | 0.020 |
Why?
|
Leptin | 1 | 2017 | 1599 | 0.020 |
Why?
|
Swine | 1 | 1999 | 5917 | 0.020 |
Why?
|
Growth Plate | 1 | 2011 | 274 | 0.020 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2011 | 370 | 0.020 |
Why?
|
Hemodynamics | 1 | 1999 | 4199 | 0.020 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2015 | 851 | 0.020 |
Why?
|
Calcium | 1 | 2022 | 5756 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2014 | 1677 | 0.020 |
Why?
|
Otolaryngology | 1 | 2016 | 645 | 0.020 |
Why?
|
Mutation | 2 | 2018 | 29786 | 0.020 |
Why?
|
Disease Progression | 2 | 2017 | 13284 | 0.020 |
Why?
|
Time Factors | 1 | 2010 | 40075 | 0.020 |
Why?
|
Visual Acuity | 1 | 2017 | 2530 | 0.020 |
Why?
|
Body Composition | 1 | 2017 | 2401 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2015 | 2539 | 0.020 |
Why?
|
Myocarditis | 1 | 2015 | 771 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 1738 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2011 | 1423 | 0.020 |
Why?
|
Prognosis | 1 | 2008 | 29063 | 0.020 |
Why?
|
Tissue and Organ Procurement | 1 | 2015 | 896 | 0.020 |
Why?
|
Bone Remodeling | 1 | 2011 | 575 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 2018 | 1537 | 0.020 |
Why?
|
Femoral Artery | 1 | 2011 | 845 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2018 | 3778 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2013 | 15076 | 0.020 |
Why?
|
Diarrhea | 1 | 2012 | 1348 | 0.020 |
Why?
|
Memory | 1 | 2015 | 2174 | 0.020 |
Why?
|
Fatigue | 1 | 2012 | 1531 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2212 | 0.020 |
Why?
|
Developing Countries | 1 | 2017 | 2815 | 0.020 |
Why?
|
Myocardial Infarction | 3 | 2010 | 11727 | 0.020 |
Why?
|
Body Height | 1 | 2011 | 1577 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2021 | 4468 | 0.020 |
Why?
|
Electrocardiography | 1 | 2018 | 6442 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 4933 | 0.020 |
Why?
|
Societies, Medical | 1 | 2016 | 3743 | 0.010 |
Why?
|
Length of Stay | 1 | 2017 | 6309 | 0.010 |
Why?
|
Staff Development | 1 | 2005 | 223 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7785 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16365 | 0.010 |
Why?
|
Weight Gain | 1 | 2012 | 2292 | 0.010 |
Why?
|
Patient Care Team | 1 | 2013 | 2531 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2023 | 15295 | 0.010 |
Why?
|
Hospitals, Teaching | 1 | 2005 | 1179 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9687 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2005 | 1850 | 0.010 |
Why?
|
Family Health | 1 | 2005 | 1282 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2012 | 10943 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2013 | 3679 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12354 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 12951 | 0.010 |
Why?
|
Quality of Life | 2 | 2010 | 12804 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2013 | 12026 | 0.010 |
Why?
|
Program Development | 1 | 2005 | 1316 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3255 | 0.010 |
Why?
|
Bone Density | 1 | 2011 | 3468 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2014 | 3445 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 2002 | 1150 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2010 | 2400 | 0.010 |
Why?
|
Public Health | 1 | 2010 | 2603 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39050 | 0.010 |
Why?
|
Logistic Models | 1 | 2010 | 13408 | 0.010 |
Why?
|
Heart Failure | 1 | 2018 | 10900 | 0.010 |
Why?
|
Oxygen | 1 | 2002 | 4189 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20129 | 0.000 |
Why?
|
Animals | 1 | 1999 | 168757 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2002 | 19905 | 0.000 |
Why?
|